Pakistan is set to host a landmark international scientific gathering as it welcomes the global space community to its ...

Analysis of Patients from CLEAR Outcomes Receiving No Other Background Lipid Lowering Therapies, Bempedoic Acid Alone Reduced MACE-4 by 14% Compared to Placebo – – An Exploratory Analysis of CLEAR ...

Sohini Ramachandran is a professor of biology, data science, and computer science at Brown University. C. Brandon Ogbunu is ...

Medifast, the health and wellness company known for its science-backed, coach-guided lifestyle system, continues to lead the charge in addressing the growing health crisis of metabolic dysfunction by ...

MolecuLight will be exhibiting at the 2025 International Post-Acute Wound Care Society (IPAWS) Summit, where the company will showcase this significant publication alongside multiple scientific ...

Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced a moderated digital poster presentation at ...

Company to also present at the Advanced Recycling Conference (Germany) and the 2nd Annual Sustainable Flexible Packaging ...

Among obstetric providers, 42.3% reported only making one allergy/immunology referral in pregnancy per year, according to ...

Data support NEK7 as a potential novel and differentiated therapeutic approach to modulate the NLRP3 inflammasome in multiple cardiovascular and ...

R&D Day showcased remarkable Investigator optimism, continued strengthening supportive data, and significant progress with Phase 3 OVATION 3 ...

MRT-8102 is a selective, potent, and durable NEK7 degrader. Activation of the NLRP3 inflammasome critically depends on NEK7. Administration of MRT-8102 led to inhibition of NLRP3 inflammasome in vitro ...

OSE-Cytomask® platform is an innovative proprietary non-cleavable linker technology to create a new class of regulated and targeted cytokine therapeutics that enables precise cytokine activation on ...